Kevin Wyman

CIK 1385599 · last filed 2011-12-23

Kevin Wyman is a corporate insider who has filed 15 SEC Form 4 insider transactions across 2 companies since 2008. Across all open-market trades the lifetime net is +$5.3M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

15

Lifetime Open-Market Net

$5.33M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVIGEN INC \DE (AVGN) Delisted 10%+ Owner 4,861,608 $10.62M 2 2009-10-23
NEPHROS INC (NEP) Delisted 10%+ Owner 1,193,994 $10.54 $12.58M -$5.29M 1 2008-05-30

Recent Filings

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2011-12-23 Sell (S) −7,410,640 -$741.1K
2009-12-22 U −24,422,540 $0
2009-10-23 AVIGEN INC \DE (AVGN) Delisted Buy (P) +2,411,950 $3.69M EDGAR
2009-10-14 AVIGEN INC \DE (AVGN) Delisted Buy (P) +4,531,295 $6.93M EDGAR
2009-08-26 Sell (S) −120,000 -$306.1K
2009-01-23 Buy (P) +1,250,000 $393.7K
2008-11-06 Buy (P) +60,500 $21.2K
2008-10-23 Buy (P) +34,500 $11.4K
2008-10-20 Buy (P) +76,000 $22.8K
2008-10-14 Buy (P) +206,500 $68.1K
Showing 110 of 15
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.